⌘K

Login Start Free

Home/Filings/144/0001140361-23-035097

144//SEC Filing

BridgeBio Pharma, Inc. 144

Accession 0001140361-23-035097

CIK 0001629482other

View on SEC.gov Company Profile

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 9:31 PM ET

Size

6.6 KB

Accession

0001140361-23-035097

Documents

1 file

144
primary_doc.xmlPrimary

Issuer

Viking Global Opportunities Illiquid Investments Sub-Master LP

CIK 0001629482

Entity typeother

IncorporatedCayman Islands

Related Parties

1

filerCIK 0001629482

Filing Metadata

Form type: 144
Filed: Jul 17, 8:00 PM ET
Accepted: Jul 18, 9:31 PM ET
Size: 6.6 KB

View on SEC.gov